Lispro Analog for Treatment of Generalized Allergy to Human Insulin

• Dinesh Kumar

  Department of Medicine, Division of Endocrinology, Diabetes, and Hypertension, University of Southern California School of Medicine, Los Angeles County Medical Center Los Angeles, California

抄録

To evaluate the clinical usefulness of the human insulin analog lispro in a patient with generalized allergy to human insulin. A 34-year-old obese female patient developed systemic allergic reactions to human insulin but tolerated insulin lispro. Sequential analyses of the anti-insulin IgE and IgG immunoglobulins were performed. On intradermal test, the lispro insulin produced a 50% less intense wheal-flare response, compared with human insulin, which was presumed to be due to lispro's molecular form. The intradermal reactivity to both human and lispro insulins decreased with time and disappeared by week 25.125I-labeled lispro and human insulin binding antibody titers of both the IgE and IgG immunoglobulins were high initially, but decreased progressively, becoming very low by the end of 1 year. In in vitro immunoassay, thelispro and human insulins show a complete cross-reactivity. Lispro may be useful for the management of allergy to human insulin. This analog of human insulin appears to have a reduced immunogenic potency.

収録刊行物

• Diabetes Care

  Diabetes Care 20 (9), 1357-1359, 1997-09-01

  American Diabetes Association

キーワード

• Advanced and Specialized Nursing
• Endocrinology, Diabetes and Metabolism
• Internal Medicine

詳細情報

• CRID: 1360574094887257600
• NII論文ID: 30026283845
• DOI: 10.2337/diacare.20.9.1357
• ISSN: 19355548
• ISSN: 01495992
• Web Site: https://diabetesjournals.org/care/article-pdf/20/9/1357/585064/20-9-1357.pdf
• データソース種別:
  • Crossref
  • CiNii Articles